Clinical Trial Update: Escalating Doses of Torisel in Combination With Three Chemotherapies Regimens: R-CHOP, R-FC or R-DHA for Patients With Relapsed/Refractory Mantle Cell Lymphoma (MCL). [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 study evaluating escalating doses of temsirolimus (Torisel) in combination with R-CHOP, R-FC, or R-DHA regimens in patients with relapsed or refract…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Torisel (Temsirolimus)

Snippet

Sponsor: The Lymphoma Academic Research Organisation | Conditions: Mantle Cell Lymphoma Refractory | Phase 1, Phase 2 | Status: COMPLETED